Inovio’s Ebola vaccine has positive results in early human trials By: MarketWatch March 30, 2016 at 10:43 AM EDT Inovio said Wednesday its Ebola vaccine was safe and effective in early-stage human trials. Read More >> Related Stocks: Gsk Plc ADR Inovio Pharma Merck & Co Newlink Genetics Cor